Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide

Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide

Interview with Joseph F. Rizzo III, MD, author of Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide. Hosted by Neil M. Bressler, MD.

Related Content:

Jaksot(127)

Validation of a Prediction Algorithm for Progression to Advanced Macular Degeneration Subtypes

Validation of a Prediction Algorithm for Progression to Advanced Macular Degeneration Subtypes

Interview with Johanna M. Seddon, MD, ScM, author of Validation of a Prediction Algorithm for Progression to Advanced Macular Degeneration Subtypes

14 Helmi 201311min

Risk Alleles in CFH and ARMS2 and the Long-term Natural History of Age-Related Macular Degeneration

Risk Alleles in CFH and ARMS2 and the Long-term Natural History of Age-Related Macular Degeneration

Interview with Ronald Klein, MD, MPH, author of Risk Alleles in CFH and ARMS2 and the Long-term Natural History of Age-Related Macular Degeneration

9 Marras 20126min

The Ophthalmic Practice of the Future

The Ophthalmic Practice of the Future

Interview with Marilyn B. Mets, MD, author of The Ophthalmic Practice of the Future.

10 Syys 201211min

Improving Preterm Ophtalmologic Care in the Era of Accountable Care Organizations

Improving Preterm Ophtalmologic Care in the Era of Accountable Care Organizations

Interview with C. Jason Wang, MD, PhD, author of Improving Preterm Ophtalmologic Care in the Era of Accountable Care Organizations.

9 Heinä 201212min

Relationship of Fuchs Endothelial Corneal Dystrophy Severity to Central Corneal Thickness

Relationship of Fuchs Endothelial Corneal Dystrophy Severity to Central Corneal Thickness

Interview with Jonathan H. Lass, MD, author of Relationship of Fuchs Endothelial Corneal Dystrophy Severity to Central Corneal Thickness

9 Huhti 20126min

Gene Therapy for Leber Congenital Amaurosis Caused by RPE65 Mutations: Safety and Efficacy in 15 Children and Adults Followed Up to 3 Years

Gene Therapy for Leber Congenital Amaurosis Caused by RPE65 Mutations: Safety and Efficacy in 15 Children and Adults Followed Up to 3 Years

Interview with Samuel G. Jacobson, MD, PhD, author of Gene Therapy for Leber Congenital Amaurosis Caused by RPE65 Mutations: Safety and Efficacy in 15 Children and Adults Followed Up to 3 Years

9 Tammi 20127min

Outcomes of Integrating Genetics in Management of Patients With Retinoblastoma

Outcomes of Integrating Genetics in Management of Patients With Retinoblastoma

Interview with Patricia Chévez-Barrios, MD, author of Outcomes of Integrating Genetics in Management of Patients With Retinoblastoma

14 Marras 201110min

Suosittua kategoriassa Tiede

rss-poliisin-mieli
rss-mita-tulisi-tietaa
tiedekulma-podcast
rss-tiedetta-vai-tarinaa
rss-lihavuudesta-podcast
hippokrateen-vastaanotolla
utelias-mieli
koodikahvit
rss-astetta-parempi-elama-podcast
rss-tervetta-skeptisyytta
university-of-eastern-finland
radio-antro
rss-duodecim-lehti
rss-duokkari-ekstra
rss-metsantuntijat-podcast
rss-ylistys-elaimille
rss-sosiopodi
rss-kasvikutsut
rss-miljonaarien-tasavalta